<DOC>
	<DOCNO>NCT00744848</DOCNO>
	<brief_summary>Effective postoperative pain control promote improve healing , faster patient mobilization , shorten hospital stay , reduce healthcare cost .</brief_summary>
	<brief_title>Study Evaluate Postoperative Analgesia Subjects Undergoing Hemorrhoidectomy</brief_title>
	<detailed_description>Effective postoperative pain control critical element patient recovery , majority patient may experience significant pain , particularly first day follow surgery . Appropriate postoperative pain management contribute improved healing , faster patient mobilization , shorten hospital stay , reduce healthcare cost .</detailed_description>
	<mesh_term>Hemorrhoids</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<criteria>Male female equal great 18 year age Screening Female subject : postmenopausal , surgically sterile , willing use acceptable mean contraception least 30 day surgery , nonheterosexual lifestyle , strictly monogamous relationship partner vasectomy . Scheduled undergo 2or3column excisional hemorrhoidectomy American Society Anesthesiology ( ASA ) Physical Class 14 Able willing complete study visit procedure Able speak , read , understand language study form instrument use collect subjectreported outcome provide accurate study assessment Willing capable provide write informed consent . Pregnant , nurse plan become pregnant study period Use longacting opioid medication within 3 day surgery opioid medication 24 hour surgery . Concurrent painful physical condition concurrent surgery may require analgesic treatment postoperative period pain strictly related procedure may interfere study assessment . Singlecolumn hemorrhoidectomy Body weight less 50 kg ( 110 pound ) History hypersensitivity idiosyncratic reaction amidetype local anesthetic , opioid medication , ingredient medication administer study ( e.g. , sulfites Marcaine epinephrine ) contraindication epinephrine contraindication paincontrol agent plan postoperative use Administration investigational drug within 30 day 5 elimination halflives investigational drug prior study drug administration History , know addiction , abuse illicit drug , prescription medicine alcohol within past 2 year . Uncontrolled anxiety schizophrenic , psychiatric disorder may interfere study assessment compliance . Significant medical condition laboratory result indicate increased vulnerability study drug procedure , expose subject unreasonable risk result participate clinical trial . Any clinically significant event condition uncover surgery A cumulative incision length le 3 cm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>hemorrhoid</keyword>
</DOC>